Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 338 followers
Latest posts
Last updated 37 minutes ago
Biogen inks $1B RayThera buyout to bag preclinical immunology assets
37 minutes ago
Biogen has struck a backloaded, $1 billion deal to buy RayThera, snagging...
F2G, Shionogi prep regulatory push after novel antifungal passes ph. 3 test
about 7 hours ago
F2G and Shionogi have released phase 3 data for the oral antifungal...
‘We think about it every day’: How Daiichi Sankyo’s R&D chief plans to stay ahead in the ADC game
about 13 hours ago
John Tsai, M.D., is rounding out his global drug development resume. Immediately...
FDA Breakthrough Therapy and RMAT: Strategic Decisions That Can Accelerate Oncology Development
about 17 hours ago
Explore how FDA Breakthrough Therapy and RMAT designations can create opportunities for...
For biopharma manufacturing at speed and scale, the future is flexible
about 17 hours ago
Biopharma development has long trended toward specialized and personalized therapies such as...
Vedana Therapeutics surfaces with $46M to develop next generation of migraine prevention therapies
about 21 hours ago
Vedana Therapeutics has emerged from stealth with $46 million in series A...
UniQure stock surges after FDA U-turn clears path to gene therapy filing
about 22 hours ago
The FDA has pulled a U-turn on uniQure’s Huntington’s disease gene therapy...
'Biopharma ecosystem is back to full health,' fueled by M&A: PwC
about 24 hours ago
With pharma and life sciences deal values surpassing $65 billion in the...
Jazz, AbCellera strike TCE discovery and development deal worth up to $792M per drug
1 day ago
Jazz Pharmaceuticals is looking to bolster its oncology research bona fides via...
Amenable FDA review bodes well for Moderna's mRNA flu shot ahead of adcomm grilling
1 day ago
With a panel of outside experts set to weigh in Thursday—and with...
Eli Lilly’s M&A spree continues with acquisition of non-opioid pain drugmaker 4E
1 day ago
Eli Lilly is taking another shot at the pain market, continuing a...
FDA clears Dexcom’s Stelo OTC glucose monitor for use with children
2 days ago
The FDA gave the green light to Dexcom’s over-the-counter glucose monitor Stelo...